This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
pcDNA-REL 9
catalog :
27266
citations: 1
Reference
Leeman J, Weniger M, Barth T, Gilmore T. Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL. Oncogene. 2008;27:6770-81 pubmed publisher
product information
Catalog Number :
27266
Product Name :
pcDNA-REL 9
article :
doi10.1038/onc.2008.284
id3903
pubmed_id18695674
bacterial resistance :
Ampicillin
cloning :
backbonepcDNA3.1(-)
backbone_mutation
backbone_originInvitrogen
backbone_size5400
promoter
sequencing_primer_3
sequencing_primer_5
vector_types
Mammalian Expression
growth notes :
Please note that Addgene's sequencing results identified a Y72H mutation when compared to GenBank entry NP_002899.1. The depositing laboratory states that this mutation does not affect protein function.
origin :
37
pi :
alt_names
cloning
clone_methodRestriction Enzyme
cloning_site_3BamHI
cloning_site_5XhoI
promoter
sequencing_primer_3BGH-Rev
sequencing_primer_5T7
site_3_destroyed
site_5_destroyed
entrez_gene
aliasesC-Rel, HIVEN86A, IMD92
geneREL
id5966
genbank_ids
mutationDeletion of exon 9- aa 308-330; Y72H
nameREL
shRNA_sequence
size
species
9606
Homo sapiens
tags
resistance markers :
871
tags :
High Copy
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
info@addgene.org
https://www.addgene.org
617.225.9000
headquarters: USA